NASDAQ · Financial Statements
Ikena Oncology, Inc. (IKNA) Financial Statements
$17.16
NASDAQ: IKNA
Market Cap $718.82M
Overview Financials Dividend Ikena Oncology, Inc. most recently reported annual revenue of $0, net profit of $-52.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $31.0M $16.0M $9.0M $0 $0 Operating Profit $-34.0M $-71.0M $-75.0M $-55.0M $-48.0M Net Profit $-34.0M $-69.0M $-68.0M $-49.0M $-52.0M EPS $-0.95 $-1.90 $-1.63 $-1.02 $0.00 Op Margin -110.2% -454.0% -823.3% — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $248.0M $172.0M $192.0M $142.0M $83.0M Total Liabilities $40.0M $25.0M $22.0M $16.0M $7.0M Cash $232.0M $60.0M $120.0M $39.0M $35.0M Borrowings $7.0M $6.0M $11.0M $8.0M $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-60.0M $-74.0M $-80.0M $-46.0M $-48.0M Investing Cash Flow $-4.0M $-101.0M $64.0M $-35.0M $-6.0M Financing Cash Flow $1.0M $0 $-1.0M $0 $135.0M Net Cash Flow $70.0M $-172.0M $60.0M $-81.0M $82.0M Free Cash Flow $-62.0M $-76.0M $-80.0M $-46.0M $-48.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 66.01 FCF Yield -7.25% Quick Ratio 18.39 Interest Coverage -44.05 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock